BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25651469)

  • 1. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
    Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
    Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study.
    Espinosa I; D'Angelo E; De Brot L; Prat J
    Hum Pathol; 2023 May; 135():1-10. PubMed ID: 36863690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.
    Le Loarer F; Zhang L; Fletcher CD; Ribeiro A; Singer S; Italiano A; Neuville A; Houlier A; Chibon F; Coindre JM; Antonescu CR
    Genes Chromosomes Cancer; 2014 Jun; 53(6):475-86. PubMed ID: 24585572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.
    Sullivan LM; Folpe AL; Pawel BR; Judkins AR; Biegel JA
    Mod Pathol; 2013 Mar; 26(3):385-92. PubMed ID: 23060122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary epithelioid sarcoma of bone: report of a unique case, with immunohistochemical and fluorescent in situ hybridization confirmation of INI1 deletion.
    Raoux D; Péoc'h M; Pedeutour F; Vaunois B; Decouvelaere AV; Folpe AL
    Am J Surg Pathol; 2009 Jun; 33(6):954-8. PubMed ID: 19342946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas.
    Rekhi B; Vogel U
    APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetics and immunophenotype of INI1/SMARCB in epithelioid sarcoma].
    Li L; Xia Q; Rao Q; Liu B; Wu B; Shi S; Yu B; Zhang R; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):389-93. PubMed ID: 25208989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
    Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
    Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
    Hornick JL; Dal Cin P; Fletcher CD
    Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular epithelioid sarcoma showing mixed classic and proximal-type features: report of 2 cases, with immunohistochemical and molecular cytogenetic INI-1 study.
    Kosemehmetoglu K; Kaygusuz G; Bahrami A; Raimondi SC; Kilicarslan K; Yildiz Y; Folpe AL
    Am J Surg Pathol; 2011 Jun; 35(6):891-7. PubMed ID: 21566521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
    Rekhi B; Jambhekar NA
    Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient Neoplasms.
    Yoshida A; Yoshida H; Yoshida M; Mori T; Kobayashi E; Tanzawa Y; Yasugi T; Kawana K; Ishikawa M; Sugiura H; Maeda D; Fukayama M; Kawai A; Hiraoka N; Motoi T
    Am J Surg Pathol; 2015 Aug; 39(8):1102-13. PubMed ID: 26171919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: miR193a-5p is suggested to downregulate SMARCB1 mRNA expression.
    Kohashi K; Yamamoto H; Kumagai R; Yamada Y; Hotokebuchi Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2014 Jun; 27(6):832-9. PubMed ID: 24287458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic determinants in epithelioid sarcoma.
    Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
    Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary EWSR1 gene abnormalities in SMARCB1-deficient tumors with 22q11-12 regional deletions: Potential pitfalls in interpreting EWSR1 FISH results.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Antonescu CR
    Genes Chromosomes Cancer; 2016 Oct; 55(10):767-76. PubMed ID: 27218413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
    Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
    Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.